Exclusive

Publication

Byline

Mint Explainer: Should you be concerned about the new covid variant?

New Delhi, April 7 -- A new variant of covid-19, called BA.3.2, has surfaced in several countries, highlighting yet again the virus's ability to continue mutating. While early reports point to a high ... Read More


Mint Explainer: What the weight-loss drug frenzy means for pharma sector and for you

New Delhi, April 1 -- On Tuesday, Danish drugmaker Novo Nordisk slashed prices of its blockbuster weight-loss and type-2 diabetes drugs Ozempic and Wegovy by up to 48%, as it faces mounting pressure f... Read More


Novo Nordisk slashes Ozempic, Wegovy prices as generic competition heats up

Mumbai, March 31 -- Innovator Novo Nordisk on Tuesday said it is reducing the starting dose prices for its semaglutide brands Ozempic and Wegovy by 36% and 48%, respectively. It will also offer an ave... Read More


Alkem eyes leadership in weight-loss drugs with aggressive generic pricing

New Delhi, March 22 -- Alkem Laboratories is positioning itself to lead India's fast-growing weight-loss drug market, driven by its in-house semaglutide development, a well-trained medical representat... Read More


India's weight-loss drug rush kicks off with generics 50-90% cheaper

MUMBAI, March 21 -- A day after semaglutide lost patent protection in India, top drugmakers including Dr Reddy's, Sun Pharma, and Zydus Lifesciences launched generic versions priced 50-90% below the i... Read More


Emcure betting on innovator edge in crowded weight-loss drug market

New Delhi, March 20 -- Emcure Pharmaceuticals, which is bringing Novo Nordisk's blockbuster semaglutide to India in an exclusive partnership, is banking on the perceived superiority and brand recognit... Read More


Prices of weight-loss drugs may halve in India

Mumbai, March 20 -- India's weight-loss drug market is on the verge of a price shake-up. In days, domestic drugmakers are set to launch cheaper versions of semaglutide, the GLP-1 (glucagon-like peptid... Read More


Natco Pharma fires first shot in weight-loss drug price war; generic semaglutide to cost 90% less at Rs.1,290 per month

MUMBAI, March 20 -- Natco Pharma has heralded what could become an intense pricing war in India's pharmaceutical sector by offering its version of generic semaglutide that's 90% cheaper than the origi... Read More


Dr Reddy's, Sun, Zydus ready semaglutide generics, weight loss drug's prices expected to halve in India

New Delhi, March 19 -- India's weight-loss drug market is on the verge of a price shake-up. In days, domestic drugmakers are set to launch cheaper versions of semaglutide, the GLP-1 (glucagon-like pe... Read More


Delhi HC upholds order allowing Dr. Reddy's to export semaglutide

New Delhi, March 9 -- In a setback for Novo Nordisk, the Delhi High Court on Monday upheld an order permitting Dr. Reddy's Laboratories to manufacture diabetes and weight-loss drug semaglutide in Indi... Read More